Search research articles
Contact Us
Filters
Showing results (541-550 of 831) with videos related to
Page
of 84
Sort By:
Neuro-Oncology
|
April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology
|
September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma
Julia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Cancer Research
|
November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
Martin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
International Journal of Cancer
|
October 15, 2014
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses
Niklas Thon, Mathias Kunz, Lena Lemke, et al.
Journal of Neurology
|
April 30, 2026
Outcome associations of CSF total tau in suspected non-Alzheimer pathophysiology
Nils Briel, Marc Borsi, Simon J Schreiner, et al.
Neuro-Oncology
|
June 13, 2017
PET imaging in patients with meningioma-report of the RANO/PET Group
Norbert Galldiks, Nathalie L Albert, Michael Sommerauer, et al.
Journal of Medicinal Chemistry
|
May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles
Christian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Acta Neuropathologica Communications
|
March 25, 2022
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients
Pierre Bady, Christine Marosi, Michael Weller, et al.
Journal of Neuro-Oncology
|
January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression
Günter Eisele, Antje Wick, Anna-Carina Eisele, et al.
Cancer Treatment Reviews
|
June 24, 2025
Surgical tumor volume reduction in patients with brain metastases: A systematic review and meta-analysis
Vittorio Stumpo, Alessandro Carretta, Jacopo Bellomo, et al.
Page
of 84
Search research articles
Search
Showing results (541-550 of 831) with videos related to
Sort By:
Page
of 84
Neuro-Oncology
|
April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology
|
September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma
Julia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Cancer Research
|
November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
Martin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
International Journal of Cancer
|
October 15, 2014
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses
Niklas Thon, Mathias Kunz, Lena Lemke, et al.
Journal of Neurology
|
April 30, 2026
Outcome associations of CSF total tau in suspected non-Alzheimer pathophysiology
Nils Briel, Marc Borsi, Simon J Schreiner, et al.
Neuro-Oncology
|
June 13, 2017
PET imaging in patients with meningioma-report of the RANO/PET Group
Norbert Galldiks, Nathalie L Albert, Michael Sommerauer, et al.
Journal of Medicinal Chemistry
|
May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles
Christian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Acta Neuropathologica Communications
|
March 25, 2022
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients
Pierre Bady, Christine Marosi, Michael Weller, et al.
Journal of Neuro-Oncology
|
January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression
Günter Eisele, Antje Wick, Anna-Carina Eisele, et al.
Cancer Treatment Reviews
|
June 24, 2025
Surgical tumor volume reduction in patients with brain metastases: A systematic review and meta-analysis
Vittorio Stumpo, Alessandro Carretta, Jacopo Bellomo, et al.
Page
of 84